MustGrow Biologics (OTCMKTS:MGROF) Stock Price Down 4.7% – Should You Sell?

Shares of MustGrow Biologics Corp. (OTCMKTS:MGROF – Get Free Report) were down 4.7% during mid-day trading on Friday. The company traded as low as C$0.26 and last traded at C$0.26. Approximately 500 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 4,974 shares. The stock had previously closed at C$0.27.

MustGrow Biologics Stock Performance

The firm has a 50 day moving average of C$0.30 and a 200-day moving average of C$0.33.

About MustGrow Biologics

(Get Free Report)

MustGrow Biologics Corp. is a Canadian agricultural biotechnology company focused on developing biological crop-protection products derived from mustard seed. Its technology is designed to harness the mustard plant’s natural defense compounds to address agricultural pests and pathogens while providing alternatives to certain conventional chemical treatments.

The company’s product development programs target soilborne diseases, nematodes and weeds. Its flagship TerraMG platform is intended for use as a biological soil treatment and biofumigant, with potential applications in crops such as fruits, vegetables and other high-value agricultural products.

Featured Articles

Receive News & Ratings for MustGrow Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MustGrow Biologics and related companies with MarketBeat.com's FREE daily email newsletter.